Literature DB >> 33817186

IGF-1 Via PI3K/Akt/S6K Signaling Pathway Protects DRG Neurons with High Glucose-induced Toxicity.

Chunhong Liu1, Siyan Liu2, Sheng Wang1, Yi Sun1, Xin Lu3, Hao Li4, Guibao Li3.   

Abstract

Hyperglycemia-induced toxicity of neurons contributes to the pathogenesis and progression of diabetic neuropathy (DNP). High concentration glucose triggered reactive oxygen species (ROS) overproduction and induced cell apoptosis of neurons from dorsal root ganglion (DRG) in vitro. Currently, there is no effective therapeutic method to retard this devastating complication or neurotoxicity induced by high glucose. Insulin-like growth factor-1 (IGF-1) has multi-neurotrophic actions which need to be explored regarding its actions and mechanisms on relieving high glucose induced neurotoxicity. Herein, high concentration glucose was exposed to the DRG neurons in vitro. The effects of IGF-1 on relieving high glucose-induced neurotoxicity were evaluated. We illustrated that IGF-1 enhanced regeneration of neurites sent from DRG neuronal cell bodies and increased neuronal viability which inhibited by high glucose challenge. IGF-1 alleviated neuronal apoptosis caused by high glucose exposure. IGF-1 also suppressed the intracellular ROS overproduction and ATF3 expression upregulation which was induced by high glucose insult. The anti-neurotoxic effects of IGF-1 might be through restoration of prosurvival PI3K/Akt/S6K signaling. These data shed some light on the treatment of intractable DNP and suggested that IGF-1 might be a potential effective agent on relieving high glucose induced neurotoxicity.
© 2019 Chunhong Liu et al., published by De Gruyter.

Entities:  

Keywords:  activating transcription factor 3; dorsal root ganglion; high glucose; insulin-like growth factor-1; neurotoxicity

Year:  2019        PMID: 33817186      PMCID: PMC7874800          DOI: 10.1515/biol-2019-0056

Source DB:  PubMed          Journal:  Open Life Sci        ISSN: 2391-5412            Impact factor:   0.938


  39 in total

Review 1.  ATF3 and stress responses.

Authors:  T Hai; C D Wolfgang; D K Marsee; A E Allen; U Sivaprasad
Journal:  Gene Expr       Date:  1999

2.  Directed axonal outgrowth using a propagating gradient of IGF-1.

Authors:  Wonjae Lee; Curtis W Frank; Jon Park
Journal:  Adv Mater       Date:  2014-03-24       Impact factor: 30.849

3.  Caffeic acid phenethyl ester alleviates asthma by regulating the airway microenvironment via the ROS-responsive MAPK/Akt pathway.

Authors:  Yuan Ma; Jia-Xiang Zhang; Ya-Nan Liu; Ai Ge; Hao Gu; Wang-Jian Zha; Xiao-Ning Zeng; Mao Huang
Journal:  Free Radic Biol Med       Date:  2016-10-13       Impact factor: 7.376

4.  The Effects of IGF-1 on TNF-α-Treated DRG Neurons by Modulating ATF3 and GAP-43 Expression via PI3K/Akt/S6K Signaling Pathway.

Authors:  Lei Zhang; Yaping Yue; Meishuo Ouyang; Huaxiang Liu; Zhenzhong Li
Journal:  Neurochem Res       Date:  2017-02-16       Impact factor: 3.996

5.  Effects of 4-phenyl butyric acid on high glucose-induced alterations in dorsal root ganglion neurons.

Authors:  Dilip Sharma; Jitendra Narain Singh; Shyam S Sharma
Journal:  Neurosci Lett       Date:  2016-10-21       Impact factor: 3.046

6.  Phosphatidylinositol 3-kinase and Akt effectors mediate insulin-like growth factor-I neuroprotection in dorsal root ganglia neurons.

Authors:  Gina M Leinninger; Carey Backus; Michael D Uhler; Stephen I Lentz; Eva L Feldman
Journal:  FASEB J       Date:  2004-08-19       Impact factor: 5.191

7.  Expression of activating transcription factor 3 (ATF3) in uninjured dorsal root ganglion neurons in a lower trunk avulsion pain model in rats.

Authors:  Yusuke Matsuura; Seiji Ohtori; Nahoko Iwakura; Takane Suzuki; Kazuki Kuniyoshi; Kazuhisa Takahashi
Journal:  Eur Spine J       Date:  2013-03-08       Impact factor: 3.134

8.  Insulin resistance-induced hyperglycemia decreased the activation of Akt/CREB in hippocampus neurons: Molecular evidence for mechanism of diabetes-induced cognitive dysfunction.

Authors:  Qiong Xiang; Jie Zhang; Chun-Yan Li; Yan Wang; Mao-Jun Zeng; Zhi-Xin Cai; Rong-Bo Tian; Wei Jia; Xian-Hui Li
Journal:  Neuropeptides       Date:  2015-09-01       Impact factor: 3.286

9.  Upregulation of CCL2 via ATF3/c-Jun interaction mediated the Bortezomib-induced peripheral neuropathy.

Authors:  Cuicui Liu; Shuo Luan; Handong OuYang; Zhenzhen Huang; Shaoling Wu; Chao Ma; Jiayou Wei; Wenjun Xin
Journal:  Brain Behav Immun       Date:  2015-11-10       Impact factor: 7.217

10.  Dysregulated IGFBP5 expression causes axon degeneration and motoneuron loss in diabetic neuropathy.

Authors:  Christian M Simon; Stefanie Rauskolb; Jennifer M Gunnersen; Bettina Holtmann; Carsten Drepper; Benjamin Dombert; Massimiliano Braga; Stefan Wiese; Sibylle Jablonka; Dirk Pühringer; Jürgen Zielasek; Andreas Hoeflich; Vincenzo Silani; Eckhard Wolf; Susanne Kneitz; Claudia Sommer; Klaus V Toyka; Michael Sendtner
Journal:  Acta Neuropathol       Date:  2015-05-30       Impact factor: 17.088

View more
  1 in total

1.  Genetic susceptibility to high myopia in Han Chinese population.

Authors:  Yufei Li; Yong Zhang; Ping Zhang; Lei Gao; Qingyue Ma; Jin Li; Shengxia Wang; Bing Liu; Xinye Wang; Chao Meng
Journal:  Open Life Sci       Date:  2022-05-17       Impact factor: 1.311

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.